Pharmaceutical Technology

JUNE 12, 2023

In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010.

Medical 143

Medical Prescription Management Manufacturing 143

Pharmaceutical Technology

MAY 29, 2008

Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. “Sales generated by new products are vital to the growth of the industry.”

Pharmaceutical 52

Pharmaceutical Marketing Sales Prescription 52

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97